These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
253 related articles for article (PubMed ID: 36762808)
1. Brain Invasion and Trends in Molecular Research on Meningioma. Go KO; Kim YZ Brain Tumor Res Treat; 2023 Jan; 11(1):47-58. PubMed ID: 36762808 [TBL] [Abstract][Full Text] [Related]
2. A new amplicon-based gene panel for next generation sequencing characterization of meningiomas. Mawrin C; Koch R; Waldt N; Sandalcioglu IE; Braunsdorf WEK; Warnke JP; Goehre F; Meisel HJ; Ewald C; Neyazi S; Schüller U; Kirches E Brain Pathol; 2022 Mar; 32(2):e13046. PubMed ID: 35213080 [TBL] [Abstract][Full Text] [Related]
3. Meningioma: current updates on genetics, classification, and mouse modeling. Szulzewsky F; Thirimanne HN; Holland EC Ups J Med Sci; 2024; 129():. PubMed ID: 38571886 [TBL] [Abstract][Full Text] [Related]
4. Genomic Landscape of Meningiomas. Wang JZ; Nassiri F; Mawrin C; Zadeh G Adv Exp Med Biol; 2023; 1416():137-158. PubMed ID: 37432625 [TBL] [Abstract][Full Text] [Related]
5. Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO. Clark VE; Erson-Omay EZ; Serin A; Yin J; Cotney J; Ozduman K; Avşar T; Li J; Murray PB; Henegariu O; Yilmaz S; Günel JM; Carrión-Grant G; Yilmaz B; Grady C; Tanrikulu B; Bakircioğlu M; Kaymakçalan H; Caglayan AO; Sencar L; Ceyhun E; Atik AF; Bayri Y; Bai H; Kolb LE; Hebert RM; Omay SB; Mishra-Gorur K; Choi M; Overton JD; Holland EC; Mane S; State MW; Bilgüvar K; Baehring JM; Gutin PH; Piepmeier JM; Vortmeyer A; Brennan CW; Pamir MN; Kiliç T; Lifton RP; Noonan JP; Yasuno K; Günel M Science; 2013 Mar; 339(6123):1077-80. PubMed ID: 23348505 [TBL] [Abstract][Full Text] [Related]
6. Oncogenic PI3K mutations are as common as AKT1 and SMO mutations in meningioma. Abedalthagafi M; Bi WL; Aizer AA; Merrill PH; Brewster R; Agarwalla PK; Listewnik ML; Dias-Santagata D; Thorner AR; Van Hummelen P; Brastianos PK; Reardon DA; Wen PY; Al-Mefty O; Ramkissoon SH; Folkerth RD; Ligon KL; Ligon AH; Alexander BM; Dunn IF; Beroukhim R; Santagata S Neuro Oncol; 2016 May; 18(5):649-55. PubMed ID: 26826201 [TBL] [Abstract][Full Text] [Related]
7. Discovering the Molecular Landscape of Meningioma: The Struggle to Find New Therapeutic Targets. Maggio I; Franceschi E; Di Nunno V; Gatto L; Tosoni A; Angelini D; Bartolini S; Lodi R; Brandes AA Diagnostics (Basel); 2021 Oct; 11(10):. PubMed ID: 34679551 [TBL] [Abstract][Full Text] [Related]
8. Non-NF2 mutations have a key effect on inhibitory immune checkpoints and tumor pathogenesis in skull base meningiomas. Hao S; Huang G; Feng J; Li D; Wang K; Wang L; Wu Z; Wan H; Zhang L; Zhang J J Neurooncol; 2019 Aug; 144(1):11-20. PubMed ID: 31177425 [TBL] [Abstract][Full Text] [Related]
9. Meningioma: Molecular Updates from the 2021 WHO Classification of CNS Tumors and Imaging Correlates. Soni N; Ora M; Bathla G; Szekeres D; Desai A; Pillai J; Agarwal A AJNR Am J Neuroradiol; 2024 Jun; ():. PubMed ID: 38844366 [TBL] [Abstract][Full Text] [Related]
10. Specific gene expression signatures of low grade meningiomas. Tsitsikov EN; Hameed S; Tavakol SA; Stephens TM; Tsytsykova AV; Garman L; Bi WL; Dunn IF Front Oncol; 2023; 13():1126550. PubMed ID: 36937440 [TBL] [Abstract][Full Text] [Related]
11. Prognostic impact of genetic alterations and methylation classes in meningioma. Berghoff AS; Hielscher T; Ricken G; Furtner J; Schrimpf D; Widhalm G; Rajky U; Marosi C; Hainfellner JA; von Deimling A; Sahm F; Preusser M Brain Pathol; 2022 Mar; 32(2):e12970. PubMed ID: 35213082 [TBL] [Abstract][Full Text] [Related]
12. First insight into the somatic mutation burden of neurofibromatosis type 2-associated grade I and grade II meningiomas: a case report comprehensive genomic study of two cranial meningiomas with vastly different clinical presentation. Dewan R; Pemov A; Dutra AS; Pak ED; Edwards NA; Ray-Chaudhury A; Hansen NF; Chandrasekharappa SC; Mullikin JC; Asthagiri AR; ; Heiss JD; Stewart DR; Germanwala AV BMC Cancer; 2017 Feb; 17(1):127. PubMed ID: 28193203 [TBL] [Abstract][Full Text] [Related]
17. YAP1-FAM118B Fusion Defines a Rare Subset of Childhood and Young Adulthood Meningiomas. Schieffer KM; Agarwal V; LaHaye S; Miller KE; Koboldt DC; Lichtenberg T; Leraas K; Brennan P; Kelly BJ; Crist E; Rusin J; Finlay JL; Osorio DS; Sribnick EA; Leonard JR; Feldman A; Orr BA; Serrano J; Vasudevaraja V; Snuderl M; White P; Magrini V; Wilson RK; Mardis ER; Boué DR; Cottrell CE Am J Surg Pathol; 2021 Mar; 45(3):329-340. PubMed ID: 33074854 [TBL] [Abstract][Full Text] [Related]
18. Clinical potential of meningioma genomic insights: a practical review for neurosurgeons. Karsy M; Azab MA; Abou-Al-Shaar H; Guan J; Eli I; Jensen RL; Ormond DR Neurosurg Focus; 2018 Jun; 44(6):E10. PubMed ID: 29852774 [TBL] [Abstract][Full Text] [Related]
19. Landscape of genetic variants in sporadic meningiomas captured with clinical genomics. Leclair NK; Shen E; Wu Q; Wolansky L; Becker K; Li L; Bulsara KR Acta Neurochir (Wien); 2022 Sep; 164(9):2491-2503. PubMed ID: 35881312 [TBL] [Abstract][Full Text] [Related]
20. Meningioma Genomics: Diagnostic, Prognostic, and Therapeutic Applications. Bi WL; Zhang M; Wu WW; Mei Y; Dunn IF Front Surg; 2016; 3():40. PubMed ID: 27458586 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]